PI Industries Vice-Chairman & MD Mayank Singhal said the company is building a strong R&D pipeline focused on discovering and developing new molecules, with regulatory approvals for its latest molecule underway. He expects the company’s growth trajectory to accelerate from FY28, with the new insecticide offering potential across markets including the US and Brazil. Singhal also outlined plans to build hi-tech manufacturing capabilities and use AI across R&D and manufacturing as PI Industries looks to become a more innovation-led company.